The goal of this program is to improve management of patients with resectable early-stage non-small cell lung cancer (NSCLC) with neoadjuvant chemoimmunotherapy. After hearing and assimilating this program, the clinician will be better able to: 1. Select patients with NSCLC for treatment with neoadjuvant chemoimmunotherapy. 2. Relate levels of inflammatory markers in patients with NSCLC to likelihood of pathological complete response.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership · $1,095/yr
| Platinum Membership | $1,095/yr |
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiac Anesthesia
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Critical Care Medicine
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Head & Neck Surgery
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Interventional Radiology
- Laryngology
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neuro Anesthesia
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Otology & Neurotology
- Pain Medicine
- Pediatric Anesthesia
- Pediatric Cardiology
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Otolaryngology
- Pediatric Radiology
- Pediatric Surgery
- Primary Care Sports Medicine
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Rhinology
- Sleep Medicine
- Surgical Critical Care
- Surgical Oncology
- Thoracic Anesthesia
- Trauma Surgery
- Vascular Surgery
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Membership pricing — $1,095 / year
This provider prices CME through membership. Individual courses may also be sold separately.
See plans on audio-digest.orgListed by the provider
- Enduring / On-demand
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
- Membership pricing
-
ReleasedSep 1, 2026
-
Last day to claim creditJan 22, 2027 3 months left
-
Society of Surgical Oncology Virtual Tumor Board: Neoadjuvant Immunotherapy
-
Answers in CME Inc. (AiCME) From Surgery to Systemic Therapy: A Collaborative Discussion on CSCC Neoadjuvant and Adjuvant Immunotherapy
-
Talem Health, LLC Neoadjuvant Therapy in Recurrent High-Risk Cutaneous Squamous Cell Carcinoma: Advancing Multidisciplinary Decision-Making
-
Learner’s Digest International (TM) Resectable Early-Stage Non-Small Cell Lung Cancer/Breast Cancer
-
Learner’s Digest International (TM) Neoadjuvant Chemo-Immunotherapy in Resectable Non-Small Cell Lung Cancer
-
Learner’s Digest International (TM) Perioperative Therapy of Resectable Non-Small Cell Lung Cancer
